G&G Medvisionsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-03-22
Share capital
5,000.00 PLN
Activity description

G&G Medvision provides clinical research services, including audits of research centers, CROs, laboratories and radiology facilities, as well as site monitoring. The company conducts, plans and organizes clinical trials, drawing on the experience of physicians, nurses, coordinators and other clinical research team members.

Registered address
Plac Tadeusza Kościuszki 12, 32-600 Oświęcim, Poland
Website
ggmedvision.com
Email
Phone
Electronic delivery address
AE:PL-24242-42577-WBATH-25

Financials

Revenue history (in k)

Filing timeliness

1 of 2 financial statements was filed late (for 2024, 260 days late).

  • 202515/04/2026
  • 202401/04/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Other research and experimental development on natural sciences and engineering1,111 / 1,565
Top 71%
Division · Scientific research and development1,358 / 1,953
Top 70%
Sector · Professional, scientific and technical activities30,945 / 39,213
Top 79%
City · Oświęcim205 / 231
Top 89%
Voivodeship · Małopolskie23,653 / 27,820
Top 85%
Country · Poland254,891 / 297,873
Top 86%

Results vs industry

Revenue
This companyUSD 14.02kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 11.04kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 1.86kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 13.91kMedianUSD 119.88kAverageUSD 3.90m

Industry

Offer

  • Medical facility audits
  • Medical facility monitoring
  • Clinical trial management
  • Clinical trial planning
  • Clinical trial organization
  • CRO services

Website technology

Website
  • WordPress

Authorized Representatives

Iwona Kobielusz Gembala – President of the Management Board
Witold Żmuda – Management Board Member

Manner of representation

In the case of a one-person management board, the President of the Management Board is authorized to make declarations of will on behalf of the company. In the case of a multi-member management board, each member of the management board is authorized to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Iwona Kobielusz Gembalaage 53
25$675.3150%
Witold Żmudaage 64
25$675.3150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2024-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Clinbitsp. z o.o.
Quantum Satissp. z o.o.
Medapp Clinical Researchsp. z o.o.
Biostat Research and Developmentsp. z o.o.
VB IdeaP.S.A.
Medaisp. z o.o.
Scilosp. z o.o.
Vitagenumsp. z o.o.

FAQ

Last updated: 2026-04-15